Haig Inguilizian

Integrative analysis reveals an outcome-associated and targetable pattern of p53 and cell cycle deregulation in diffuse large B cell lymphoma.

Stefano Monti, Ahmet Dogan, Donna Neuberg, 2012, Cancer cell.

The intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemia.

Gabriela Alexe, Giovanni Roti, Nicola Tolliday, 2012, The Journal of clinical investigation.

Successful within-patient dose escalation of olipudase alfa in acid sphingomyelinase deficiency.

E. Shamiyeh, G. Diaz, H. Soran, 2015, Molecular genetics and metabolism.

The JAK2V617F oncogene requires expression of inducible phosphofructokinase/fructose-bisphosphatase 3 for cell growth and increased metabolic activity

O. Abdel-Wahab, R. Levine, J. Griffin, 2011, Leukemia.

A phase I, first-in-human study of TAK-164, an antibody–drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase C

D. Ryan, A. Parikh, B. Bahamon, 2023, Cancer Chemotherapy and Pharmacology.

The intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemia.

W. Hahn, K. Ross, J. Aster, 2012, The Journal of clinical investigation.